Olmeda Bárbara, Martínez-Calle Marta, Pérez-Gil Jesus
Department of Biochemistry, Faculty of Biology, and Research Institute "Hospital 12 de Octubre", Complutense University, 28040 Madrid, Spain.
Department of Biochemistry, Faculty of Biology, and Research Institute "Hospital 12 de Octubre", Complutense University, 28040 Madrid, Spain.
Ann Anat. 2017 Jan;209:78-92. doi: 10.1016/j.aanat.2016.09.008. Epub 2016 Oct 20.
Pulmonary surfactant is a lipid-protein complex that lines and stabilizes the respiratory interface in the alveoli, allowing for gas exchange during the breathing cycle. At the same time, surfactant constitutes the first line of lung defense against pathogens. This review presents an updated view on the processes involved in biogenesis and intracellular processing of newly synthesized and recycled surfactant components, as well as on the extracellular surfactant transformations before and after the formation of the surface active film at the air-water interface. Special attention is paid to the crucial regulation of surfactant homeostasis, because its disruption is associated with several lung pathologies.
肺表面活性物质是一种脂质-蛋白质复合物,它排列并稳定肺泡中的呼吸界面,使呼吸周期中能够进行气体交换。同时,表面活性物质构成了肺部抵御病原体的第一道防线。本综述对新合成和循环利用的表面活性物质成分的生物合成及细胞内加工过程,以及在气-水界面形成表面活性膜之前和之后的细胞外表面活性物质转化过程提出了更新的观点。特别关注了表面活性物质稳态的关键调节,因为其破坏与多种肺部疾病相关。